Carl Byrnes Analyst PerformanceManaging Director at Northland SecuritiesCarl Byrnes is a stock analyst at Northland Securities in the medical sector, covering 10 publicly traded companies. Over the past year, Carl Byrnes has issued 5 stock ratings, including and buy recommendations. While full access to Carl Byrnes' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Carl Byrnes' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings48 Last 7 YearsBuy Recommendations89.13% 41 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution46RatingsDistribution of strong buy, buy, hold, and sell ratings by Carl Byrnes.RatingPercentageCount Strong Buy0.0%0 ratings Buy89.1%41 ratings Hold10.9%5 ratings Sell0.0%0 ratingsOut of 46 total stock ratings issued by Carl Byrnes at Northland Securities, the majority (89.1%) have been Buy recommendations, followed by 10.9% Hold.Best & Worst CallsBest Call0000.0%BLFSAug 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NBRVMay 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ10 companiesCarl Byrnes, an analyst at Northland Securities, currently covers 10 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical10 companies100.0%Carl Byrnes of Northland Securities specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - DRUGS3 companies30.0%MED PRODUCTS3 companies30.0%MED - BIOMED/GENE2 companies20.0%PHARMACEUTICAL PREPARATIONS2 companies20.0% About Carl ByrnesCarl Byrnes is a Senior Equity Research Analyst covering the biopharmaceutical, life sciences, and enabling technologies segment of the life sciences sectors. His areas of expertise include: addictive disorders and overdose rescue therapeutics; anti-infectives; cardiovascular and ischemic disease; central nervous system disorders including epilepsy; degenerative neurologic disorders including Alzheimer’s and Parkinson’s disease; endocrinology; oncology; osteoarthritis; pain management; and pulmonary disorders including cystic fibrosis. Carl has over 25 years of experience in biotechnology research and pharmaceuticals. His previous experience includes senior equity research roles at RBC Capital Markets, Lehman Brothers, and Bank of America Securities. He also served as a senior manager with Pfizer, Inc. and as President and CEO of SCS Refrigerated Services. Carl was also a Treasurer and Trustee of the Pacific Northwest Research Institute (PNRI). Carl is a graduate of Washington University in St. Louis and completed his MBA at Cornell University’s Johnson Graduate School of Management. Carl Byrnes' Ratings History at Northland Securities Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRCELAvita Medical3/5/2026Initiated Coverage$4.96$10.00Outperform$0.0000.00% ROIBWAYBrainsway1/22/2026Set Price Target$12.21$15.00$0.0000.00% ROIBWAYBrainsway11/12/2025Boost Price Target$7.92$11.50Outperform$0.0000.00% ROISNWVSanuwave Health9/3/2025Initiated Coverage$39.75$55.00Outperform$0.0000.00% ROIBWAYBrainsway8/14/2025Boost Price Target$6.43$9.50Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
